Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Lens

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
World Journal of Gastroenterology|May 9, 2015
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CSabela Lens, Jose L Calleja, Ana Campillo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2023
Anticancer drugs are the first cause of drug-induced liver injury in a reference hospitalAnna Pocurull, Maria José Moreta, David Heitman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2025
HBcrAg and cirB-RNA Do Not Predict Clinical and Virological Outcomes in Patients With HBeAg-Negative Chronic InfectionSara Battistella, Thais Leonel, Anna Pocurull, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian PatientsAnna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
Plos One|November 19, 2016
Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without InterferonMartina Gambato, Noelia Caro-Pérez, Patricia González, et al.
Plos One|January 21, 2017
Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without InterferonMartina Gambato, Noelia Caro-Pérez, Patricia González, et al.
Hepatology International|September 9, 2022
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver diseaseYuanyuan Kong, Tingting Lv, Min Li, et al.
Frontiers in Public Health|August 4, 2023
Chronic conditions and multimorbidity among West African migrants in greater Barcelona, SpainMarina J MacKinnon, Camila A Picchio, Daniel K Nomah, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2018
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosisMartina Gambato, Laetitia Canini, Sabela Lens, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
World Journal of Gastroenterology|May 9, 2015
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CSabela Lens, Jose L Calleja, Ana Campillo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 22, 2023
Anticancer drugs are the first cause of drug-induced liver injury in a reference hospitalAnna Pocurull, Maria José Moreta, David Heitman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2025
HBcrAg and cirB-RNA Do Not Predict Clinical and Virological Outcomes in Patients With HBeAg-Negative Chronic InfectionSara Battistella, Thais Leonel, Anna Pocurull, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 14, 2025
Determinants of HBsAg Loss After Nucleos(t)ide Discontinuation in a Prospective Cohort of HBeAg-Negative Caucasian PatientsAnna Pocurull, Teresa Broquetas, Elena Hoyas, et al.
Plos One|November 19, 2016
Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without InterferonMartina Gambato, Noelia Caro-Pérez, Patricia González, et al.
Plos One|January 21, 2017
Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without InterferonMartina Gambato, Noelia Caro-Pérez, Patricia González, et al.
Hepatology International|September 9, 2022
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver diseaseYuanyuan Kong, Tingting Lv, Min Li, et al.
Frontiers in Public Health|August 4, 2023
Chronic conditions and multimorbidity among West African migrants in greater Barcelona, SpainMarina J MacKinnon, Camila A Picchio, Daniel K Nomah, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2018
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosisMartina Gambato, Laetitia Canini, Sabela Lens, et al.
Pageof 17